MICHAEL DAVANZO: Open Payments
NPI 1285864991 · SNEADS FERRY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 81 payments from 18 companies in 2025. Trend: 2023 $18 · 2024 $153 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $344 |
| AstraZeneca Pharmaceuticals LP | 7 | $209 |
| ABBVIE INC. | 15 | $209 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $138 |
| TOLMAR, INC. | 5 | $126 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Amgen Inc. | 4 | $59 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
Products named: Wegovy, XIFAXAN, JATENZO, AIRSUPRA, Ozempic, QULIPTA, BREZTRI, VRAYLAR.
Industry payments across NC — which companies pay providers there.
